Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA disputes prostate drugs' risk-cutting power
FDA disputes prostate drugs' risk-cutting power
FDA disputes prostate drugs' risk-cutting power
Submitted by
admin
on November 30, 2010 - 10:59am
Source:
Fierce Pharma
News Tags:
FDA
GSK
prostate cancer
Avodart
Merck
Proscar
Headline:
FDA disputes prostate drugs' risk-cutting power
Do Not Allow Advertisers to Use My Personal information
